A Phase II Study of Modified FOLFOX4 for Colorectal Cancer Patients with Peritoneal Carcinomatosis

PURPOSE: Peritoneal carcinomatosis (PC) of colorectal cancer (CRC) is common and is the second most common cause of death. Clinical studies regarding chemotherapy for CRC with PC have been classically rather limited in scope. We evaluated the efficacy of modified oxaliplatin, leucovorin, and fluorou...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Dong Hyun, Oh, Sung Yong, Lee, Yu Rim, Huh, Seok Jae, Yoon, Hyun Hwa, Kim, Sung Hyun, Lee, Suee, Lee, Ji Hyun, Kim, Young, Kim, Hyo-Jin, Kwon, Hyuk-Chan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253864/
https://www.ncbi.nlm.nih.gov/pubmed/22247707
http://dx.doi.org/10.4143/crt.2011.43.4.225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253864/
https://www.ncbi.nlm.nih.gov/pubmed/22247707
http://dx.doi.org/10.4143/crt.2011.43.4.225

Ejemplares similares